One of the attorneys general leading the multistate effort, Pennsylvania Attorney General Josh Shapiro, said in a July 26 press release the agreement “ensures Teva will pay for its irresponsible actions.”
More than half a billion dollars in the settlement has already been included in previous trials. Part of the settlement instructs Teva to fund $1.2 billion worth of naloxone, a generic used to treat opioid overdoses, for the next decade. Native American tribes will receive $100 million, the Times reported.
In a statement, Teva said, “While the agreement will include no admission of wrongdoing, it remains in our best interest to put these cases behind us and continue to focus on the patients we serve every day,” according to the Times.
The states involved in the case include California, Illinois, Iowa, Massachusetts, New York, North Carolina, Pennsylvania, Tennessee, Texas, Vermont, Virginia and Wisconsin.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
